Issuer Newsroom

Sinclair Method UK Ltd

Wire Volume: 3 Disclosures

Corporate Disclosures & Press Wire (3)

ONS figures show fall in alcohol deaths as improved treatments take effect
LONDON, UK - May 28, 2025··Healthcare & Life Sciences

ONS figures show fall in alcohol deaths as improved treatments take effect

The Office for National Statistics (ONS) reports a decline in alcohol-specific deaths in the UK for the first time since 2018, with 9,809 deaths recorded in 2024. This decrease is partly attributed to the growing use of moderation therapies, such as The Sinclair Method, which help individuals manage alcohol consumption without requiring complete abstinence. Despite the overall decline, regional and gender disparities persist, highlighting the need for targeted interventions and accessible treatm

Read disclosure →
Fruity summer beers may mask problem drinking with their ‘deceptively easy’ appeal
LONDON, UK - May 19, 2026··Healthcare & Life Sciences

Fruity summer beers may mask problem drinking with their ‘deceptively easy’ appeal

A leading alcohol reduction expert warns that the rising popularity of fruit-flavoured beers, such as blueberry variants, could lead to overconsumption due to their easy-to-drink nature. These beverages, often perceived as refreshing and lower in alcohol content, may encourage people to drink more than intended, especially during social gatherings. Sinclair Method UK is launching a summer awareness campaign to promote responsible drinking and offer support for moderation strategies, including me

Read disclosure →
Weight‑loss ‘wonder drug’ may also curb alcohol cravings - but proven treatments already exist
LONDON, UK - March 17, 2026··Healthcare & Life Sciences

Weight‑loss ‘wonder drug’ may also curb alcohol cravings - but proven treatments already exist

Research indicates that semaglutide, found in weight-loss and diabetes drugs like Wegovy and Ozempic, may also reduce alcohol cravings. However, experts caution against using these drugs for alcohol reduction, as they are not approved for this purpose and proven treatments like naltrexone already exist. The NHS only endorses semaglutide for diabetes and obesity, and further studies are needed to validate its effectiveness for alcohol misuse.

Read disclosure →